After the Cure: Management of HCV After Achievement of SVR
Abstract Co-infection with HIV and HCV is associated with accelerated progression of liver disease and increased complications compared with HCV infection alone. Treatment of HCV and achievement of a sustained virologic response (SVR) can improve outcomes in these patients. Even after clearance of the hepatitis C virus, however, patients remain at risk, albeit diminished, for the complications of chronic liver disease. As such, longitudinal monitoring of treated patients remains important for clinicians caring for this population. This article summarizes the benefits and persistent risks after attaining SVR. It reviews the natural history of fibrosis and addresses the monitoring and management of progressive liver disease..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Current HIV AIDS reports - 10(2013), 4 vom: 12. Nov., Seite 428-435 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zator, Zachary A. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© Springer Science+Business Media New York 2013 |
|---|
| doi: |
10.1007/s11904-013-0181-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2028975113 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2028975113 | ||
| 003 | DE-627 | ||
| 005 | 20230517033602.0 | ||
| 007 | tu | ||
| 008 | 200819s2013 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11904-013-0181-9 |2 doi | |
| 035 | |a (DE-627)OLC2028975113 | ||
| 035 | |a (DE-He213)s11904-013-0181-9-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Zator, Zachary A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a After the Cure: Management of HCV After Achievement of SVR |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media New York 2013 | ||
| 520 | |a Abstract Co-infection with HIV and HCV is associated with accelerated progression of liver disease and increased complications compared with HCV infection alone. Treatment of HCV and achievement of a sustained virologic response (SVR) can improve outcomes in these patients. Even after clearance of the hepatitis C virus, however, patients remain at risk, albeit diminished, for the complications of chronic liver disease. As such, longitudinal monitoring of treated patients remains important for clinicians caring for this population. This article summarizes the benefits and persistent risks after attaining SVR. It reviews the natural history of fibrosis and addresses the monitoring and management of progressive liver disease. | ||
| 650 | 4 | |a Hepatitis C, Chronic/drug therapy | |
| 650 | 4 | |a Hepatitis C, Chronic/virology | |
| 650 | 4 | |a Hepatitis C, Chronic/epidemiology | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Coinfection/drug therapy | |
| 650 | 4 | |a Treatment outcome | |
| 650 | 4 | |a Elasticity imaging techniques | |
| 650 | 4 | |a End stage liver disease/etiology | |
| 650 | 4 | |a Liver cirrhosis/complications | |
| 650 | 4 | |a Liver cirrhosis/mortality | |
| 650 | 4 | |a Liver cirrhosis/physiopathology | |
| 650 | 4 | |a Liver cirrhosis/virology | |
| 650 | 4 | |a Liver diseases/prevention & control | |
| 650 | 4 | |a Liver diseases/virology | |
| 650 | 4 | |a Tissue elasticity imaging | |
| 650 | 4 | |a Carcinoma, Hepatocellular | |
| 650 | 4 | |a HIV infections | |
| 700 | 1 | |a Chung, Raymond T. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current HIV AIDS reports |d Springer US, 2004 |g 10(2013), 4 vom: 12. Nov., Seite 428-435 |w (DE-627)390611921 |w (DE-600)2151206-1 |x 1548-3568 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2013 |g number:4 |g day:12 |g month:11 |g pages:428-435 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11904-013-0181-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2013 |e 4 |b 12 |c 11 |h 428-435 | ||